Charlotte Hyldgaard1, Ole Hilberg2, Audrey Muller3, Elisabeth Bendstrup2. 1. Department of Respiratory Medicine and Allergology, Aarhus University Hospital, Denmark. Electronic address: chahyl@rm.dk. 2. Department of Respiratory Medicine and Allergology, Aarhus University Hospital, Denmark. 3. Actelion Pharmaceuticals Ltd, Allschwil, Switzerland.
Abstract
INTRODUCTION: Interstitial lung diseases (ILDs) form a heterogeneous group of diseases with varying degrees of inflammation and fibrosis. Epidemiological data based on the current diagnostic criteria are sparse. OBJECTIVES: To characterize the incidence rate of ILDs and idiopathic pulmonary fibrosis (IPF) in Danish patients diagnosed at a referral hospital, to evaluate disease severity and survival in these ILD patients and to compare the use of the 2001 and 2011 guidelines to diagnosis of IPF. METHODS: Single-centre, retrospective, observational cohort study including incident patients diagnosed with ILD at Aarhus University Hospital between 2003 and 2009. All diagnoses were re-evaluated according to current diagnostic criteria. Disease severity in IPF was assessed using the GAP index. RESULTS: The ILD incidence was 4.1 per 100,000 inhabitants/year. IPF was the most common diagnosis (28%) followed by connective tissue disease-related ILD (14%), hypersensitivity pneumonitis (7%) and non-specific interstitial pneumonia (NSIP) (7%). The GAP index was a strong predictor of survival in IPF. Twenty-three patients who had IPF based on the 2001 criteria had a "possible UIP" HRCT pattern but no lung biopsy, and IPF could therefore not be diagnosed based on the 2011 criteria. CONCLUSION: ILD and IPF incidence was 4.1 and 1.3 per 100,000 inhabitants/year. The diagnostic re-evaluation raised the number of IPF diagnoses, but a diagnostic "grey zone" was still evident in patients with UIP features not qualifying the patients to be diagnosed with IPF. The GAP index was valuable as a measure of IPF severity in this cohort.
INTRODUCTION:Interstitial lung diseases (ILDs) form a heterogeneous group of diseases with varying degrees of inflammation and fibrosis. Epidemiological data based on the current diagnostic criteria are sparse. OBJECTIVES: To characterize the incidence rate of ILDs and idiopathic pulmonary fibrosis (IPF) in Danish patients diagnosed at a referral hospital, to evaluate disease severity and survival in these ILDpatients and to compare the use of the 2001 and 2011 guidelines to diagnosis of IPF. METHODS: Single-centre, retrospective, observational cohort study including incident patients diagnosed with ILD at Aarhus University Hospital between 2003 and 2009. All diagnoses were re-evaluated according to current diagnostic criteria. Disease severity in IPF was assessed using the GAP index. RESULTS: The ILD incidence was 4.1 per 100,000 inhabitants/year. IPF was the most common diagnosis (28%) followed by connective tissue disease-related ILD (14%), hypersensitivitypneumonitis (7%) and non-specific interstitial pneumonia (NSIP) (7%). The GAP index was a strong predictor of survival in IPF. Twenty-three patients who had IPF based on the 2001 criteria had a "possible UIP" HRCT pattern but no lung biopsy, and IPF could therefore not be diagnosed based on the 2011 criteria. CONCLUSION:ILD and IPF incidence was 4.1 and 1.3 per 100,000 inhabitants/year. The diagnostic re-evaluation raised the number of IPF diagnoses, but a diagnostic "grey zone" was still evident in patients with UIP features not qualifying the patients to be diagnosed with IPF. The GAP index was valuable as a measure of IPF severity in this cohort.
Authors: Fernando Pedraza-Serrano; Ana López de Andrés; Rodrigo Jiménez-García; Isabel Jiménez-Trujillo; Valentín Hernández-Barrera; Gema Sánchez-Muñoz; Luis Puente-Maestu; Javier de Miguel-Díez Journal: BMJ Open Date: 2017-02-13 Impact factor: 2.692
Authors: Elisabeth Bendstrup; Charlotte Hyldgaard; Alan Altraja; Tone Sjåheim; Marjukka Myllärniemi; Gunnar Gudmundsson; Magnus Sköld; Ole Hilberg Journal: Eur Clin Respir J Date: 2015-07-01
Authors: Matthieu Storme; Alexandre Semionov; Deborah Assayag; Michael Lefson; Darlene Kitty; David Dannenbaum; Jill Torrie; Pierre Lejeune; Elizabeth Robinson; Faiz Ahmad Khan Journal: PLoS One Date: 2017-09-08 Impact factor: 3.240
Authors: Toby M Maher; Elisabeth Bendstrup; Louis Dron; Jonathan Langley; Gerald Smith; Javaria Mona Khalid; Haridarshan Patel; Michael Kreuter Journal: Respir Res Date: 2021-07-07